Podcast
Questions and Answers
Which of the following is NOT a type of anti-obesity drug currently in development?
Which of the following is NOT a type of anti-obesity drug currently in development?
- Cholesterol-lowering agents (correct)
- Gut hormones and incretin targets
- Anti-obesity vaccines
- Centrally acting agents
Which of the following is a dual action GLP-1/glucagon receptor agonist?
Which of the following is a dual action GLP-1/glucagon receptor agonist?
- Tesofensine
- Oxyntomodulin (correct)
- Velneperit
- Setmelanotide
What type of receptor is targeted by cannabinoid type-1 receptor blockers?
What type of receptor is targeted by cannabinoid type-1 receptor blockers?
- Neuropeptide Y receptor
- Fibroblast growth factor 21 receptor
- Glucagon-like peptide-1 receptor
- Cannabinoid type-1 receptor (correct)
Which of the following is a triple agonist?
Which of the following is a triple agonist?
What is the mechanism of action of the methionine aminopeptidase 2 inhibitor beloranib?
What is the mechanism of action of the methionine aminopeptidase 2 inhibitor beloranib?
Which of the following is a potential adverse effect of using lorcaserin with drugs that affect serotonin?
Which of the following is a potential adverse effect of using lorcaserin with drugs that affect serotonin?
What is the main purpose of anorexiants in the treatment of obesity?
What is the main purpose of anorexiants in the treatment of obesity?
Which of the following anorexiants was voluntarily withdrawn from the U.S. market due to cardiovascular side effects in October 2010?
Which of the following anorexiants was voluntarily withdrawn from the U.S. market due to cardiovascular side effects in October 2010?
Why were fenfluramine (Pondimin) and dexfenfluramine (Redux) removed from the market in 1997?
Why were fenfluramine (Pondimin) and dexfenfluramine (Redux) removed from the market in 1997?
What is the pharmacodynamic mechanism of anorexiants in the treatment of obesity?
What is the pharmacodynamic mechanism of anorexiants in the treatment of obesity?
Which of the following anorexiants is chemically and pharmacologically related to amphetamines?
Which of the following anorexiants is chemically and pharmacologically related to amphetamines?
Which two drugs are available for chronic weight management as unique combinations?
Which two drugs are available for chronic weight management as unique combinations?
What is the primary mechanism of action of lorcaserin in promoting satiety?
What is the primary mechanism of action of lorcaserin in promoting satiety?
Which of the following statements about the pharmacokinetics of anorexiants is correct?
Which of the following statements about the pharmacokinetics of anorexiants is correct?
Which of the following is a known contraindication for the use of anorexiants?
Which of the following is a known contraindication for the use of anorexiants?
What is the mechanism of action of topiramate in combination with phentermine for weight loss?
What is the mechanism of action of topiramate in combination with phentermine for weight loss?
Which of the following is a potential adverse effect of lorcaserin?
Which of the following is a potential adverse effect of lorcaserin?
What is the primary route of administration for liraglutide?
What is the primary route of administration for liraglutide?
Which of the following is a contraindication for the use of liraglutide?
Which of the following is a contraindication for the use of liraglutide?
What is the typical half-life of anorexiants?
What is the typical half-life of anorexiants?
Which of the following adverse reactions is commonly associated with the use of liraglutide?
Which of the following adverse reactions is commonly associated with the use of liraglutide?
What is the main concern with long-term use of anorexiants?
What is the main concern with long-term use of anorexiants?
Which of the following is NOT a potential adverse effect associated with liraglutide?
Which of the following is NOT a potential adverse effect associated with liraglutide?
What is the recommended course of treatment duration for anorexiants?
What is the recommended course of treatment duration for anorexiants?
Which of the following statements regarding lorcaserin is TRUE?
Which of the following statements regarding lorcaserin is TRUE?
Which of the following anorexiants is considered one of the safest for patients with mild to moderate hypertension or angina pectoris?
Which of the following anorexiants is considered one of the safest for patients with mild to moderate hypertension or angina pectoris?
What is the recommended starting dose of liraglutide in the first week?
What is the recommended starting dose of liraglutide in the first week?
Which of the following statements regarding anorexiants and evening dosing is TRUE?
Which of the following statements regarding anorexiants and evening dosing is TRUE?
Which of the following is a potential drug interaction associated with anorexiants?
Which of the following is a potential drug interaction associated with anorexiants?
Which of the following statements regarding liraglutide administration is TRUE?
Which of the following statements regarding liraglutide administration is TRUE?
Which of the following is a potential adverse effect associated with liraglutide?
Which of the following is a potential adverse effect associated with liraglutide?
Which of the following anorexiants is NOT a stimulant?
Which of the following anorexiants is NOT a stimulant?